Detrended Fluctuation Analysis independently predicts all-cause mortality of patients with Sarcoidosis

E. Gialafos (Athens Attiki, Greece)

Source: International Congress 2017 – Novel and old entities
Session: Novel and old entities
Session type: Thematic Poster
Number: 3843

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Gialafos (Athens Attiki, Greece). Detrended Fluctuation Analysis independently predicts all-cause mortality of patients with Sarcoidosis. 3843

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality
Source: Eur Respir J 2010; 36: 1002-1006
Year: 2010



Predictor factors of mortality in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 808s
Year: 2006

Effect of Multiple Comorbidities on Mortality in COPD
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020

Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Analysis of NEWS2 trend to predict risk of death in COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


Copeptin predicts all-cause mortality in stable COPD: An analysis of the COSYCONET study
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis
Source: Virtual Congress 2021 – Pneumonia
Year: 2021


Analysis of the risk factors related to in-hospital deaths in patients with tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 504s
Year: 2006

Survival predictors of severe community-acquired pneumonia (CAP): Multivariate analysis of immunological and inflammatory parameters
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Late Breaking Abstract - High-sensitivity troponin I predicts all-cause mortality in stable COPD in the COSYCONET cohort
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018

Predictors of 30-day mortality in elderly patients with community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Hematological parameters- as mortality predictors in COVID-19 patients
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Patient pathway modelling using Discrete Event Simulation to reduce readmissions in COPD
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019

Meta-analysis of FEV1 as a risk factor for all-cause mortality
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003

High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study
Source: Eur Respir J, 55 (2) 1901314; 10.1183/13993003.01314-2019
Year: 2020



Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013


Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Survival characteristics and predictors of mortality in COPD subjects
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019

Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009